Suggestions

Du même auteur

Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

Archive ouverte | Creutzberg, Carien | CCSD

International audience. The Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Consensus Conference on Clinical Research (ECCC) was held in Incheon, South Korea, Nov 2-3, 2023. The aims were to develop consensu...

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Archive ouverte | Oaknin, Ana | CCSD

International audience. The GOG240 trial established bevacizumab with chemotherapy as standard first-line therapy for metastatic or recurrent cervical cancer. In the BEATcc trial (ENGOT-Cx10-GEICO 68-C-JGOG1084-GOG-...

739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial. L’année 2021 dans tous ses états : une synthèse digérée

Archive ouverte | Sabatier, Renaud | CCSD

International audience. 5548 Background: Ovarian cancer is the leading cause of death by gynecological cancer. Complete surgery remains one of the main prognostic factors. Laparoscopic exploration is mandatory to as...

Chargement des enrichissements...